As the fight against the Coronavirus gathers steam, experts have opined that the deadline of August 15 given by ICMR to Bharat Biotech to ready the vaccine for COVID-19 might be largely impractical. This is, however, despite the fact that India normally combines Phase 1 and Phase 2 of the trials and that is what they plan to do in this case.

It may be recollected that the COVAXIN was approved post animal trials and the next step that starts on July 07 is the human trials. In all, 1125 persons will be administered the COVAXIN of which 375 would be administered in Phase 1. After both the phases, the DGCI will take a call to introduce the drug on compassionate grounds.